TipRanks
Go Ultimate55% OFF

Perfect Medical Health Management Limited (1830) AI Stock Analysis

HK:1830

Perfect Medical Health Management Limited

(HKEX:1830)

Select Model
Rating:68Neutral
Price Target:HKD 1.50â–²(31.58% Upside)
Action:downgraded
Date:10/19/26

Strong profitability, cash generation, leverage, and attractive valuation are the main supports. These are offset by declining revenue and clearly weak technical momentum, resulting in an overall score of 68.

Positive Factors
Strong ProfitabilityGross, EBIT, and net margins of roughly 47%, 22%, and 19% show the company remains meaningfully profitable despite recent contraction. This profitability provides an operating cushion and supports reinvestment, pricing resilience, and continued service delivery over the next several quarters.
Negative Factors
Revenue ContractionRevenue declined for two consecutive years, with reported revenue growth of about -14.7%. Persistent top-line contraction can weaken operating leverage, reduce scale benefits, and make future profit growth harder unless customer demand and sales momentum recover over coming periods.

Perfect Medical Health Management Limited (1830) vs. iShares MSCI Hong Kong ETF (EWH)

-20%-15%-10%-5%0%5%10%15%20%HK:1830-7.47%EWH+7.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
HKD 1.43B
Dividend Yield
12.76%
Average Volume (3M)
445.07K
Price to Earnings (P/E)
8.0
Beta (1Y)
0.62
Revenue Growth
-14.68%
EPS Growth
-13.60%
Country
Hong Kong
Employees
787
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Perfect Medical Health Management Limited Business Overview & Revenue Model

Company Description

Operating as an investment holding firm, Perfect Medical Health Management Limited delivers a comprehensive suite of medical and aesthetic services across Hong Kong, mainland China, Macau, Singapore, and Australia. Its offerings encompass medical aes...

Perfect Medical Health Management Limited Financial Statement Overview

Summary

Strong profitability and cash generation support the score, with solid margins, healthy free cash flow, and improved debt-to-equity. Revenue declines and reduced assets and equity are moderate weaknesses.

Income Statement

74Positive

Balance Sheet

71Positive

Cash Flow

79Positive
Financial statement breakdown
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue962.35M962.35M1.13B1.39B1.39B1.35B
Gross Profit538.03M454.45M719.22M911.37M662.60M689.93M
EBITDA368.03M369.52M441.97M596.91M592.40M602.84M
Net Income178.72M178.72M206.90M315.80M315.64M305.25M
Balance Sheet
Total Assets834.20M834.20M935.91M1.22B1.30B1.28B
Cash, Cash Equivalents and Short-Term Investments294.93M294.93M386.80M567.40M656.85M454.37M
Total Debt134.58M134.58M216.65M268.73M240.35M311.07M
Total Liabilities446.33M446.33M557.18M725.00M684.02M786.93M
Stockholders Equity387.86M387.86M379.95M497.51M612.27M494.27M
Cash Flow
Free Cash Flow309.22M309.22M298.23M445.50M533.81M372.16M
Operating Cash Flow339.48M339.48M332.88M497.12M560.55M516.71M
Investing Cash Flow-180.16M-180.16M-171.93M162.56M-222.51M8.05M
Financing Cash Flow-269.94M-269.94M-477.95M-520.97M-335.02M-565.97M

Perfect Medical Health Management Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price1.14

Price Trends

50DMA1.24Negative
100DMA1.23Negative
200DMA1.18Negative

Market Momentum

MACD-0.03Negative
RSI37.54Neutral
STOCH67.10Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1830, the sentiment is Negative. The current price of 1.14 is below the 20-day moving average (MA) of 1.16, below the 50-day MA of 1.24, and below the 200-day MA of 1.18, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 37.54 is Neutral, neither overbought nor oversold. The STOCH value of 67.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1830.

Perfect Medical Health Management Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

HK:1830 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:1830HK:183068NeutralHKD 1.43B8.0143.78%12.76%-14.68%-13.60%
HK:1448HK:144856NeutralHKD 6.03B14.006.50%20.98%――
HK:8483HK:848355NeutralHKD 248.00M-24.54-77.06%―-38.43%-394.12%
HK:2521HK:252152NeutralHKD 1.80B49.266.47%―2.78%-41.23%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
HK:0919HK:091950NeutralHKD 67.84M-37.50-0.93%―-2.31%66.07%
HK:8296HK:829647NeutralHKD 17.95M-0.76-17.95%―-26.00%-188.55%

* Healthcare Sector Average

Performance Comparison

0%100%200%HK:1830HK:1448HK:0919HK:8296HK:8483HK:2521Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
HK:1830 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:1830Perfect Medical Health Management Limited1.14-0.08-6.79%
HK:1448Fu Shou Yuan International Group 2.64-0.25-8.69%
HK:0919Modern Healthcare Technology Holdings Limited0.070.004.17%
HK:8296Sino-Life Group Limited0.19-0.19-50.00%
HK:8483Max Sight Group Holdings Limited0.310.22248.31%
HK:2521Shenghui Cleanness Group Holdings Limited0.930.53131.25%

Perfect Medical Health Management Limited Corporate Events

Perfect Medical Announces Board Resignation and Committee Reshuffle

Sep 30, 2026

Perfect Medical Health Management Limited has announced the resignation of independent non-executive director Mr. Chi Chi Hung, Kenneth, effective 30 September 2026. His departure also covers his roles as chairman of the remuneration committee and as...

Perfect Medical Updates Board and Committee Structure to Strengthen Governance

Sep 30, 2026

Perfect Medical Health Management Limited has outlined the composition of its board of directors effective 30 September 2026, led by Chairman and Chief Executive Officer Dr. Au-Yeung Kong and supported by three executive and three independent non-exe...

Perfect Medical Wins Strong Shareholder Backing at AGM

Aug 7, 2026

Perfect Medical Health Management Limited reported that all resolutions at its 7 August 2026 annual general meeting were passed by poll with overwhelming shareholder support, including adoption of the audited results for the year ended 31 March 2026...

Perfect Medical Proposes Re-Appointment of PwC as Auditor

Jul 21, 2026

Perfect Medical Health Management Limited, a Cayman Islands-incorporated company listed in Hong Kong, operates in the healthcare and medical services sector. Its group’s business scope and operational scale have remained largely unchanged from...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 19, 2026